Skip to main content
GKSolverGKSolver
HomeExam NewsMCQsMainsUPSC Prep
Login
Menu
Daily
HomeDaily NewsExam NewsStudy Plan
Practice
Essential MCQsEssential MainsUPSC PrepBookmarks
Browse
EditorialsStory ThreadsTrending
Home
Daily
MCQs
Saved
News

© 2025 GKSolver. Free AI-powered UPSC preparation platform.

AboutContactPrivacyTermsDisclaimer
GKSolverGKSolver
HomeExam NewsMCQsMainsUPSC Prep
Login
Menu
Daily
HomeDaily NewsExam NewsStudy Plan
Practice
Essential MCQsEssential MainsUPSC PrepBookmarks
Browse
EditorialsStory ThreadsTrending
Home
Daily
MCQs
Saved
News

© 2025 GKSolver. Free AI-powered UPSC preparation platform.

AboutContactPrivacyTermsDisclaimer
4 minOther

This Concept in News

1 news topics

1

Supreme Court examines mandatory NAT testing for safer blood transfusions

3 March 2026

The news about the Supreme Court considering mandatory NAT testing for blood banks directly challenges the continued reliance on ELISA as the primary screening method. This highlights the trade-off between cost and accuracy in public health decisions. While ELISA has been a workhorse for decades due to its affordability and ease of use, its lower sensitivity compared to NAT means that some infected blood may slip through the screening process, leading to preventable infections. The news reveals that the cost of NAT is a significant barrier to its widespread adoption, particularly in resource-constrained settings. However, the potential for preventing life-threatening infections, especially in vulnerable populations like Thalassemia patients, justifies a closer look at the cost-benefit analysis. Understanding ELISA's limitations and the advantages of newer technologies like NAT is crucial for analyzing the ethical and economic implications of blood screening policies. This news underscores the need for a balanced approach that considers both the cost and the potential health benefits of different screening methods.

4 minOther

This Concept in News

1 news topics

1

Supreme Court examines mandatory NAT testing for safer blood transfusions

3 March 2026

The news about the Supreme Court considering mandatory NAT testing for blood banks directly challenges the continued reliance on ELISA as the primary screening method. This highlights the trade-off between cost and accuracy in public health decisions. While ELISA has been a workhorse for decades due to its affordability and ease of use, its lower sensitivity compared to NAT means that some infected blood may slip through the screening process, leading to preventable infections. The news reveals that the cost of NAT is a significant barrier to its widespread adoption, particularly in resource-constrained settings. However, the potential for preventing life-threatening infections, especially in vulnerable populations like Thalassemia patients, justifies a closer look at the cost-benefit analysis. Understanding ELISA's limitations and the advantages of newer technologies like NAT is crucial for analyzing the ethical and economic implications of blood screening policies. This news underscores the need for a balanced approach that considers both the cost and the potential health benefits of different screening methods.

  1. होम
  2. /
  3. अवधारणाएं
  4. /
  5. Other
  6. /
  7. Enzyme-Linked Immunosorbent Assay (ELISA)
Other

Enzyme-Linked Immunosorbent Assay (ELISA)

Enzyme-Linked Immunosorbent Assay (ELISA) क्या है?

The Enzyme-Linked Immunosorbent Assay (ELISA) is a widely used biochemical technique to detect the presence of an antibody or an antigen in a sample. Think of it as a highly specific detective that can identify tiny amounts of a particular substance. It's called 'enzyme-linked' because it uses an enzyme to create a signal that indicates the presence and quantity of the target substance. ELISA exists because it provides a relatively simple, cost-effective, and highly sensitive method for detecting and quantifying specific substances in biological samples. It serves the purpose of diagnosing diseases, monitoring immune responses, and conducting research in various fields like medicine, immunology, and biotechnology.

ऐतिहासिक पृष्ठभूमि

ELISA was developed in the late 1960s and early 1970s. Its invention is generally credited to Peter Perlmann and Eva Engvall at Stockholm University in Sweden. The need for ELISA arose from the limitations of existing immunoassays, which were often complex, time-consuming, or lacked the sensitivity required for certain applications. ELISA offered a significant improvement in terms of simplicity, speed, and sensitivity. Over the years, ELISA has undergone several refinements and variations, including the development of different assay formats (e.g., direct, indirect, sandwich, competitive ELISA) and the use of different enzyme-substrate systems to enhance signal detection. It became a cornerstone technique in various fields, particularly in diagnostics and research, and continues to be widely used today.

मुख्य प्रावधान

12 points
  • 1.

    ELISA relies on the principle of antigen-antibody interaction. An antigen is a substance that triggers an immune response, while an antibody is a protein produced by the body to neutralize the antigen. ELISA uses these interactions to detect and quantify the presence of specific antigens or antibodies in a sample.

  • 2.

    There are several types of ELISA, including direct, indirect, sandwich, and competitive ELISA. Each type has its own advantages and disadvantages, and the choice of which type to use depends on the specific application and the characteristics of the target substance.

  • 3.

    In a direct ELISA, an antigen is immobilized on a surface, and an enzyme-labeled antibody is added. The antibody binds directly to the antigen, and the enzyme activity is measured to determine the amount of antigen present. This is simpler but less sensitive.

  • 4.

वास्तविक दुनिया के उदाहरण

1 उदाहरण

यह अवधारणा 1 वास्तविक उदाहरणों में दिखाई दी है अवधि: Mar 2026 से Mar 2026

Supreme Court examines mandatory NAT testing for safer blood transfusions

3 Mar 2026

The news about the Supreme Court considering mandatory NAT testing for blood banks directly challenges the continued reliance on ELISA as the primary screening method. This highlights the trade-off between cost and accuracy in public health decisions. While ELISA has been a workhorse for decades due to its affordability and ease of use, its lower sensitivity compared to NAT means that some infected blood may slip through the screening process, leading to preventable infections. The news reveals that the cost of NAT is a significant barrier to its widespread adoption, particularly in resource-constrained settings. However, the potential for preventing life-threatening infections, especially in vulnerable populations like Thalassemia patients, justifies a closer look at the cost-benefit analysis. Understanding ELISA's limitations and the advantages of newer technologies like NAT is crucial for analyzing the ethical and economic implications of blood screening policies. This news underscores the need for a balanced approach that considers both the cost and the potential health benefits of different screening methods.

संबंधित अवधारणाएं

Article 21 of the Constitution of IndiaNucleic Acid Testing (NAT)cost-effectiveness in public health policy

स्रोत विषय

Supreme Court examines mandatory NAT testing for safer blood transfusions

Polity & Governance

UPSC महत्व

ELISA is relevant for GS-3 (Science and Technology), particularly in the context of health and disease. It can also be relevant for GS-2 (Social Justice) when discussing access to healthcare and diagnostic technologies. Questions may focus on the principles of ELISA, its applications in disease diagnosis, its advantages and limitations compared to other diagnostic techniques, and recent developments in ELISA technology. In prelims, expect factual questions about the types of ELISA and their applications. In mains, you might be asked to compare ELISA with other diagnostic methods like PCR or NAT, or to discuss the ethical considerations related to the use of ELISA in screening programs. Understanding the trade-offs between cost, sensitivity, and specificity is crucial for answering such questions. It's frequently asked because it's a foundational technology in diagnostics.
❓

सामान्य प्रश्न

6
1. What's the most common MCQ trap regarding ELISA types (direct, indirect, sandwich, competitive)?

The most common trap is confusing the order of antibody binding and enzyme labeling. Students often incorrectly assume that in indirect ELISA, the primary antibody is enzyme-labeled. The correct order is: antigen immobilized, unlabeled primary antibody, then enzyme-labeled secondary antibody. Examiners test this by presenting options with incorrect labeling sequences.

परीक्षा युक्ति

Remember 'Indirect' means *another* antibody is used for detection, hence the secondary antibody is labeled, not the primary.

2. ELISA is used to detect both antigens and antibodies. How does the *sample preparation* differ when testing for each?

When testing for an antigen, the sample is prepared to *isolate and present the antigen* in a purified or semi-purified form. This might involve cell lysis, protein extraction, or chromatography. When testing for antibodies, the sample (usually serum or plasma) is often used *directly* or with minimal dilution, assuming the antibodies are already present in the liquid fraction. The key difference is whether you're trying to extract the target or just make it accessible.

On This Page

DefinitionHistorical BackgroundKey PointsReal-World ExamplesRelated ConceptsUPSC RelevanceSource TopicFAQs

Source Topic

Supreme Court examines mandatory NAT testing for safer blood transfusionsPolity & Governance

Related Concepts

Article 21 of the Constitution of IndiaNucleic Acid Testing (NAT)cost-effectiveness in public health policy
  1. होम
  2. /
  3. अवधारणाएं
  4. /
  5. Other
  6. /
  7. Enzyme-Linked Immunosorbent Assay (ELISA)
Other

Enzyme-Linked Immunosorbent Assay (ELISA)

Enzyme-Linked Immunosorbent Assay (ELISA) क्या है?

The Enzyme-Linked Immunosorbent Assay (ELISA) is a widely used biochemical technique to detect the presence of an antibody or an antigen in a sample. Think of it as a highly specific detective that can identify tiny amounts of a particular substance. It's called 'enzyme-linked' because it uses an enzyme to create a signal that indicates the presence and quantity of the target substance. ELISA exists because it provides a relatively simple, cost-effective, and highly sensitive method for detecting and quantifying specific substances in biological samples. It serves the purpose of diagnosing diseases, monitoring immune responses, and conducting research in various fields like medicine, immunology, and biotechnology.

ऐतिहासिक पृष्ठभूमि

ELISA was developed in the late 1960s and early 1970s. Its invention is generally credited to Peter Perlmann and Eva Engvall at Stockholm University in Sweden. The need for ELISA arose from the limitations of existing immunoassays, which were often complex, time-consuming, or lacked the sensitivity required for certain applications. ELISA offered a significant improvement in terms of simplicity, speed, and sensitivity. Over the years, ELISA has undergone several refinements and variations, including the development of different assay formats (e.g., direct, indirect, sandwich, competitive ELISA) and the use of different enzyme-substrate systems to enhance signal detection. It became a cornerstone technique in various fields, particularly in diagnostics and research, and continues to be widely used today.

मुख्य प्रावधान

12 points
  • 1.

    ELISA relies on the principle of antigen-antibody interaction. An antigen is a substance that triggers an immune response, while an antibody is a protein produced by the body to neutralize the antigen. ELISA uses these interactions to detect and quantify the presence of specific antigens or antibodies in a sample.

  • 2.

    There are several types of ELISA, including direct, indirect, sandwich, and competitive ELISA. Each type has its own advantages and disadvantages, and the choice of which type to use depends on the specific application and the characteristics of the target substance.

  • 3.

    In a direct ELISA, an antigen is immobilized on a surface, and an enzyme-labeled antibody is added. The antibody binds directly to the antigen, and the enzyme activity is measured to determine the amount of antigen present. This is simpler but less sensitive.

  • 4.

वास्तविक दुनिया के उदाहरण

1 उदाहरण

यह अवधारणा 1 वास्तविक उदाहरणों में दिखाई दी है अवधि: Mar 2026 से Mar 2026

Supreme Court examines mandatory NAT testing for safer blood transfusions

3 Mar 2026

The news about the Supreme Court considering mandatory NAT testing for blood banks directly challenges the continued reliance on ELISA as the primary screening method. This highlights the trade-off between cost and accuracy in public health decisions. While ELISA has been a workhorse for decades due to its affordability and ease of use, its lower sensitivity compared to NAT means that some infected blood may slip through the screening process, leading to preventable infections. The news reveals that the cost of NAT is a significant barrier to its widespread adoption, particularly in resource-constrained settings. However, the potential for preventing life-threatening infections, especially in vulnerable populations like Thalassemia patients, justifies a closer look at the cost-benefit analysis. Understanding ELISA's limitations and the advantages of newer technologies like NAT is crucial for analyzing the ethical and economic implications of blood screening policies. This news underscores the need for a balanced approach that considers both the cost and the potential health benefits of different screening methods.

संबंधित अवधारणाएं

Article 21 of the Constitution of IndiaNucleic Acid Testing (NAT)cost-effectiveness in public health policy

स्रोत विषय

Supreme Court examines mandatory NAT testing for safer blood transfusions

Polity & Governance

UPSC महत्व

ELISA is relevant for GS-3 (Science and Technology), particularly in the context of health and disease. It can also be relevant for GS-2 (Social Justice) when discussing access to healthcare and diagnostic technologies. Questions may focus on the principles of ELISA, its applications in disease diagnosis, its advantages and limitations compared to other diagnostic techniques, and recent developments in ELISA technology. In prelims, expect factual questions about the types of ELISA and their applications. In mains, you might be asked to compare ELISA with other diagnostic methods like PCR or NAT, or to discuss the ethical considerations related to the use of ELISA in screening programs. Understanding the trade-offs between cost, sensitivity, and specificity is crucial for answering such questions. It's frequently asked because it's a foundational technology in diagnostics.
❓

सामान्य प्रश्न

6
1. What's the most common MCQ trap regarding ELISA types (direct, indirect, sandwich, competitive)?

The most common trap is confusing the order of antibody binding and enzyme labeling. Students often incorrectly assume that in indirect ELISA, the primary antibody is enzyme-labeled. The correct order is: antigen immobilized, unlabeled primary antibody, then enzyme-labeled secondary antibody. Examiners test this by presenting options with incorrect labeling sequences.

परीक्षा युक्ति

Remember 'Indirect' means *another* antibody is used for detection, hence the secondary antibody is labeled, not the primary.

2. ELISA is used to detect both antigens and antibodies. How does the *sample preparation* differ when testing for each?

When testing for an antigen, the sample is prepared to *isolate and present the antigen* in a purified or semi-purified form. This might involve cell lysis, protein extraction, or chromatography. When testing for antibodies, the sample (usually serum or plasma) is often used *directly* or with minimal dilution, assuming the antibodies are already present in the liquid fraction. The key difference is whether you're trying to extract the target or just make it accessible.

On This Page

DefinitionHistorical BackgroundKey PointsReal-World ExamplesRelated ConceptsUPSC RelevanceSource TopicFAQs

Source Topic

Supreme Court examines mandatory NAT testing for safer blood transfusionsPolity & Governance

Related Concepts

Article 21 of the Constitution of IndiaNucleic Acid Testing (NAT)cost-effectiveness in public health policy

In an indirect ELISA, the antigen is immobilized, and an unlabeled primary antibody is added. Then, an enzyme-labeled secondary antibody that binds to the primary antibody is added. This amplifies the signal and increases sensitivity. Think of it as using a magnifying glass to see something small.

  • 5.

    A sandwich ELISA involves capturing the antigen between two antibodies. A capture antibody is immobilized on a surface, and the antigen is allowed to bind to it. Then, a second enzyme-labeled antibody is added, which binds to a different site on the antigen. This is highly specific and sensitive.

  • 6.

    A competitive ELISA measures the amount of antigen in a sample by comparing it to a known amount of antigen. The sample antigen and a known amount of labeled antigen compete for binding to a limited amount of antibody. The amount of label detected is inversely proportional to the amount of antigen in the sample.

  • 7.

    The enzyme used in ELISA catalyzes a reaction that produces a detectable signal, such as a color change or fluorescence. The intensity of the signal is proportional to the amount of antigen or antibody present in the sample. Common enzymes used include horseradish peroxidase (HRP) and alkaline phosphatase (ALP).

  • 8.

    ELISA is widely used in diagnostics to detect infectious diseases, such as HIV, hepatitis, and malaria. For example, an ELISA test can detect the presence of HIV antibodies in a blood sample, indicating that the person has been infected with HIV.

  • 9.

    ELISA is also used to measure hormone levels, such as thyroid hormones and reproductive hormones. This can help diagnose endocrine disorders and monitor the effectiveness of hormone therapy.

  • 10.

    In research, ELISA is used to study immune responses, identify biomarkers, and develop new diagnostic tests and therapies. For example, ELISA can be used to measure the levels of cytokines (small proteins important in cell signaling) in a sample, providing insights into the immune response in a particular disease.

  • 11.

    While ELISA is a powerful tool, it has limitations. It can be prone to false positive and false negative results, and it may not be suitable for detecting very low levels of a target substance. Newer techniques like NAT (Nucleic Acid Amplification Testing) are more sensitive for detecting viruses directly.

  • 12.

    The cost of ELISA tests can vary depending on the specific test and the laboratory performing the test. However, ELISA is generally less expensive than more advanced techniques like NAT, which is why it's still widely used, especially in resource-limited settings.

  • 3. Why is ELISA still used for HIV detection when more sensitive tests like NAT (Nucleic Acid Amplification Testing) exist?

    Despite NAT's higher sensitivity, ELISA remains valuable due to its lower cost, higher throughput, and suitability for large-scale screening, especially in resource-limited settings. While NAT can detect the virus earlier in the infection, ELISA is effective for detecting antibodies produced later. The Supreme Court is examining mandating NAT in blood banks, indicating a potential shift, but ELISA's cost-effectiveness keeps it relevant.

    4. In a sandwich ELISA, what happens if you reverse the order of adding the capture antibody and the detection antibody?

    Reversing the order will likely result in a *failed assay*. The capture antibody *must* be immobilized first to bind the antigen from the sample. If the detection antibody is added first, it will not be able to bind the antigen effectively, as the antigen will not be concentrated or 'captured' on the solid surface. This significantly reduces sensitivity and specificity.

    परीक्षा युक्ति

    Remember: Capture *before* detection in a sandwich ELISA. Think of it like building a sandwich – you need the bread (capture antibody) *before* you put the filling (antigen) and the top slice (detection antibody).

    5. How does the Drugs and Cosmetics Act, 1940, relate to ELISA-based diagnostic kits, and what are the implications for quality control?

    The Drugs and Cosmetics Act, 1940, regulates the manufacture, sale, and distribution of ELISA-based diagnostic kits in India. This means that these kits must meet certain quality standards and undergo rigorous testing to ensure their accuracy and reliability. Implications for quality control include mandatory licensing, adherence to Good Manufacturing Practices (GMP), and post-market surveillance to monitor performance and address any adverse events or inaccuracies. This helps ensure the reliability of diagnostic results and protects public health.

    6. What are the ethical considerations surrounding the use of ELISA in large-scale screening programs, particularly concerning false positives?

    Large-scale ELISA screening can generate false positives, leading to unnecessary anxiety, further testing, and potential stigmatization. Ethical considerations include: 1) The need for confirmatory tests to minimize false positives. 2) Ensuring informed consent and counseling for individuals undergoing screening. 3) Protecting privacy and confidentiality of test results. 4) Addressing potential inequities in access to confirmatory testing and treatment. Balancing the benefits of early detection with the risks of false positives is crucial.

    In an indirect ELISA, the antigen is immobilized, and an unlabeled primary antibody is added. Then, an enzyme-labeled secondary antibody that binds to the primary antibody is added. This amplifies the signal and increases sensitivity. Think of it as using a magnifying glass to see something small.

  • 5.

    A sandwich ELISA involves capturing the antigen between two antibodies. A capture antibody is immobilized on a surface, and the antigen is allowed to bind to it. Then, a second enzyme-labeled antibody is added, which binds to a different site on the antigen. This is highly specific and sensitive.

  • 6.

    A competitive ELISA measures the amount of antigen in a sample by comparing it to a known amount of antigen. The sample antigen and a known amount of labeled antigen compete for binding to a limited amount of antibody. The amount of label detected is inversely proportional to the amount of antigen in the sample.

  • 7.

    The enzyme used in ELISA catalyzes a reaction that produces a detectable signal, such as a color change or fluorescence. The intensity of the signal is proportional to the amount of antigen or antibody present in the sample. Common enzymes used include horseradish peroxidase (HRP) and alkaline phosphatase (ALP).

  • 8.

    ELISA is widely used in diagnostics to detect infectious diseases, such as HIV, hepatitis, and malaria. For example, an ELISA test can detect the presence of HIV antibodies in a blood sample, indicating that the person has been infected with HIV.

  • 9.

    ELISA is also used to measure hormone levels, such as thyroid hormones and reproductive hormones. This can help diagnose endocrine disorders and monitor the effectiveness of hormone therapy.

  • 10.

    In research, ELISA is used to study immune responses, identify biomarkers, and develop new diagnostic tests and therapies. For example, ELISA can be used to measure the levels of cytokines (small proteins important in cell signaling) in a sample, providing insights into the immune response in a particular disease.

  • 11.

    While ELISA is a powerful tool, it has limitations. It can be prone to false positive and false negative results, and it may not be suitable for detecting very low levels of a target substance. Newer techniques like NAT (Nucleic Acid Amplification Testing) are more sensitive for detecting viruses directly.

  • 12.

    The cost of ELISA tests can vary depending on the specific test and the laboratory performing the test. However, ELISA is generally less expensive than more advanced techniques like NAT, which is why it's still widely used, especially in resource-limited settings.

  • 3. Why is ELISA still used for HIV detection when more sensitive tests like NAT (Nucleic Acid Amplification Testing) exist?

    Despite NAT's higher sensitivity, ELISA remains valuable due to its lower cost, higher throughput, and suitability for large-scale screening, especially in resource-limited settings. While NAT can detect the virus earlier in the infection, ELISA is effective for detecting antibodies produced later. The Supreme Court is examining mandating NAT in blood banks, indicating a potential shift, but ELISA's cost-effectiveness keeps it relevant.

    4. In a sandwich ELISA, what happens if you reverse the order of adding the capture antibody and the detection antibody?

    Reversing the order will likely result in a *failed assay*. The capture antibody *must* be immobilized first to bind the antigen from the sample. If the detection antibody is added first, it will not be able to bind the antigen effectively, as the antigen will not be concentrated or 'captured' on the solid surface. This significantly reduces sensitivity and specificity.

    परीक्षा युक्ति

    Remember: Capture *before* detection in a sandwich ELISA. Think of it like building a sandwich – you need the bread (capture antibody) *before* you put the filling (antigen) and the top slice (detection antibody).

    5. How does the Drugs and Cosmetics Act, 1940, relate to ELISA-based diagnostic kits, and what are the implications for quality control?

    The Drugs and Cosmetics Act, 1940, regulates the manufacture, sale, and distribution of ELISA-based diagnostic kits in India. This means that these kits must meet certain quality standards and undergo rigorous testing to ensure their accuracy and reliability. Implications for quality control include mandatory licensing, adherence to Good Manufacturing Practices (GMP), and post-market surveillance to monitor performance and address any adverse events or inaccuracies. This helps ensure the reliability of diagnostic results and protects public health.

    6. What are the ethical considerations surrounding the use of ELISA in large-scale screening programs, particularly concerning false positives?

    Large-scale ELISA screening can generate false positives, leading to unnecessary anxiety, further testing, and potential stigmatization. Ethical considerations include: 1) The need for confirmatory tests to minimize false positives. 2) Ensuring informed consent and counseling for individuals undergoing screening. 3) Protecting privacy and confidentiality of test results. 4) Addressing potential inequities in access to confirmatory testing and treatment. Balancing the benefits of early detection with the risks of false positives is crucial.